Entitlement Efforts Clause Samples

The Entitlement Efforts clause defines the obligations of a party to diligently pursue and obtain all necessary permits, approvals, or rights required for a project or transaction. In practice, this clause typically requires the responsible party to take reasonable steps, such as submitting applications, responding to governmental inquiries, and addressing any conditions imposed by authorities. Its core function is to ensure that the project can proceed without legal or regulatory delays by clearly assigning responsibility for securing entitlements.
Entitlement Efforts. Tenant acknowledges that Landlord has received approvals from the City’s Architectural Review Board (“ARB”) and the Planning and Community Environment Director for the Base Building Work (as defined and described in Exhibit D) and has received applicable demolition, grading and building permits from the City. Accordingly, Tenant has no right to modify the Base Building Construction Drawings, except as set forth in Section 2.5 of Exhibit D. Landlord shall have the right to determine all aspects of the strategy and timing for any additional submissions to and correspondence with governmental authorities regarding the development of the Building.
View Source
Entitlement Efforts. Entitler covenants to use reasonable commercial efforts to obtain the Entitlements on or before the end of the Entitlement Period. Such reasonable efforts shall include, without limitation, Ordinary Procedures and Extraordinary Procedures. Entitler shall keep Assister informed at all times regarding the proposed efforts, plans, and timeline to obtain the Entitlements and shall duly consider Assister's comments and proposals. Assister shall cooperate with and lend reasonable aid and assistance to Entitler as to the planning of the Gull Project. Entitler and Assister shall confer on a regular basis, but not less than once per week, during the term of this Agreement as to the Gull Project (See Section 17(p) below).
View Source
Entitlement Efforts. Tenant acknowledges that as of the Effective Date, the tentative site plan attached as Exhibit A that has been developed by Landlord for development and construction of the Building is preliminary and therefore subject to change. Landlord agrees to use commercially reasonable efforts to keep Tenant informed of any material changes to the design of the Building during the City approval process. Landlord shall have primary responsibility for pursuing all necessary City entitlements and approvals for the Base Building Work through the expiration of all appeal periods at Landlord’s cost and expense (the “Entitlement Efforts”). Landlord shall have the right to determine all aspects of the strategy and timing for all submissions and applications to all governmental authorities regarding the Entitlement Efforts for the development of the Building with the goal of obtaining approval of the Building and construction of the Base Building Work in accordance with the Work Letter with the timing of delivery of the Premises to Tenant as anticipated in this Lease. Tenant acknowledges that the process for obtaining approval from the City is subject to City discretion, fluid and iterative, and therefore, the design may be subject to change based upon feedback and conditions of approval from the City. Tenant agrees to support Landlord’s Entitlement Efforts and to make its chief executive officer or other “C-Level” executive available (or another senior company representative if scheduling conflicts so require) to participate in City hearings and meetings regarding the Entitlement Efforts for the development of the Building.
View Source

Related to Entitlement Efforts

  • Agent Efforts Upon the terms and subject to the conditions set forth in this Agreement, upon the receipt of an Issuance Notice, the Agent will use its commercially reasonable efforts consistent with its normal sales and trading practices to place the Shares with respect to which the Agent has agreed to act as sales agent, subject to, and in accordance with the information specified in, the Issuance Notice, unless the sale of the Shares described therein has been suspended, cancelled or otherwise terminated in accordance with the terms of this Agreement. For the avoidance of doubt, the parties to this Agreement may modify an Issuance Notice at any time provided they both agree in writing to any such modification.

  • Joint Efforts To the full extent permitted by law, neither this Agreement nor any ambiguity or uncertainty herein will be construed against any of the parties hereto, whether under any rule of construction or otherwise. On the contrary, this Agreement has been prepared by the joint efforts of the respective attorneys for, and has been reviewed by, each of the parties hereto.

  • Development Efforts 4.2.1 Hana shall use Commercially Reasonable Efforts to Develop each Product in the Territory (including carrying out its responsibilities under the Development Plan) to: (a) conduct or cause to be conducted the necessary and appropriate clinical trials as necessary to obtain and maintain Regulatory Approvals for each Product; and (b) prepare, file and prosecute or cause to be prepared, filed and prosecuted the Regulatory Submission for each Product. 4.2.2 Hana will provide INEX with written reports to keep INEX fully informed of the progress of the Development of each Product as follows: (a) at the close of each Calendar Quarter during the first twenty-four (24) months following the Effective Date of the Definitive Agreements; and (b) on or before June 31 and December 31 of each and every calendar year thereafter.

  • Joint Effort The preparation of this Agreement has been a joint effort of the parties, and the resulting document shall not be construed more severely against one of the parties than the other.

  • Diligent Efforts Pfizer and Xenogen Cranbury each shall use reasonably diligent efforts to achieve the objectives of the Research Program. Xenogen Cranbury will use reasonably diligent efforts to achieve the objectives listed in the Research Plan and Pfizer will use reasonably diligent efforts to assist Xenogen Cranbury in such efforts.